Search results
Pfizer Moves Forward With Weight-Loss Pill. The Stock Is Rising.
Barrons.com· 25 minutes agoPfizer stock was rising Thursday after the pharmaceutical company said it was moving forward with...
Pfizer moves forward with once-daily weight loss pill after scrapping earlier version
AOL· 1 hour agoThe new drug is part of the second-generation of weight-loss pills, under development by companies including Eli Lilly and Novo Nordisk ...
GLP-1 Concerns Clobbered This Healthcare Stock. It’s Time to Buy.
Barrons.com· 7 hours agoResMed makes its bank from products that battle sleep apnea. When that business seemed threatened,...
FTC preparing suit against drug middlemen over insulin rebates
Los Angeles Times· 12 hours agoThe Federal Trade Commission is preparing a lawsuit against the three largest drug intermediaries...
US Senator Sanders optimistic Novo Nordisk can be pressured to cut Wegovy, Ozempic prices
Reuters via Yahoo Canada News· 15 hours ago-Senator Bernie Sanders on Wednesday expressed confidence that Novo Nordisk can be convinced to cut...
ESSENCE Fest 2024: Medical Experts Call For Inclusive And Compassionate Health Care For Black...
Essence· 16 hours ago...Gynecology at Health Alliance Hospital; and Kelly Copes-Anderson, Global Head of Diversity,...
US FTC to sue drug middlemen over insulin prices, source says
AOL· 18 hours ago(Reuters) -The U.S. Federal Trade Commission is planning to sue UnitedHealth, Cigna and CVS Health over their tactics as middlemen in negotiating prices for drugs including ...
FTC to sue drug managers amid insulin price hikes
Investing.com via Yahoo Finance Canada· 20 hours agoInvesting.com - The Federal Trade Commission (FTC) is gearing up to sue the top three pharmacy-benefit managers (PBMs) over their strategies for negotiating drug prices, including insulin. This ...
3 Generic Drug Stocks to Watch Amid Improving Market Prospects
Zacks via Yahoo Finance Canada· 20 hours agoWith the ease in inflationary pressure, the Zacks Medical - Generic Drugs industry is expected to...
Most patients stop using Wegovy, Ozempic for weight loss within two years, analysis finds
The Globe and Mail· 24 hours agoThe analysis does not include details about why patients quit. Evidence that many people may stop...